OTC Products - Republic of the Congo

Republic of the Congo

In the Republic of the Congo, the projected revenue in the OTC Products market is estimated to reach US$64.36m in 2024.
This market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 2.42%, resulting in a market volume of US$72.55m by 2029.
When compared globally, China is anticipated to generate the highest revenue in the OTC Products market, reaching US$74.91bn in 2024.
In terms of per person revenues, in the Republic of the Congo is expected to generate US$10.31 in 2024.
The Republic of the Congo is experiencing a growing demand for OTC products due to an increase in healthcare awareness among its population.

Key regions: Europe, Australia, United Kingdom, Germany, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Products (Pharmacies) market in Republic of the Congo is experiencing significant growth and development.

Customer preferences: Customers in the Republic of the Congo have shown a strong preference for over-the-counter (OTC) products in recent years. This can be attributed to several factors, including the convenience and accessibility of OTC products compared to prescription medications. Additionally, customers in the Republic of the Congo often prefer self-medication for minor ailments and common health issues, which further drives the demand for OTC products.

Trends in the market: One notable trend in the OTC Products (Pharmacies) market in the Republic of the Congo is the increasing availability and variety of OTC products. Pharmacies in the country are expanding their product offerings to meet the growing demand from customers. This includes a wider range of medications for common ailments such as cold and flu, pain relief, and digestive issues. Furthermore, there is a growing trend towards natural and herbal remedies, as customers seek alternative options for their healthcare needs.

Local special circumstances: The Republic of the Congo has a relatively underdeveloped healthcare system, with limited access to healthcare facilities and professionals, particularly in rural areas. As a result, pharmacies play a crucial role in providing healthcare services to the population. Pharmacies often serve as the first point of contact for individuals seeking medical advice and treatment, making OTC products an essential component of healthcare in the country.

Underlying macroeconomic factors: The growth and development of the OTC Products (Pharmacies) market in the Republic of the Congo can be attributed to several underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income and improved living standards for many individuals. This has contributed to a greater willingness and ability to spend on healthcare products, including OTC medications. Additionally, the government of the Republic of the Congo has implemented policies and initiatives to promote the development of the healthcare sector. This includes efforts to improve access to healthcare services and increase the availability of essential medications. These initiatives have created a favorable environment for the growth of the OTC Products (Pharmacies) market in the country. In conclusion, the OTC Products (Pharmacies) market in the Republic of the Congo is experiencing significant growth and development. Customer preferences for convenience and self-medication, along with the increasing availability and variety of OTC products, are driving this growth. The underdeveloped healthcare system and the role of pharmacies as primary healthcare providers also contribute to the demand for OTC products. The underlying macroeconomic factors, including economic growth and government initiatives, further support the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.